IPN Sponsors

  The ABCD Insulin Pump Network is grateful to the following organisations for supporting the operational activity of the Insulin Pump Network

ABCD Corporate Pump and Device Supporters

Gold sponsors
Cellnono Logo


Combining the latest in insulin pump technology with m-Health Cellnovo is proud to have developed our mobile diabetes management system in the UK and launched in 2014 at selected UK centres. Cellnovo products are manufactured in South Wales and having secured additional funding through an IPO in 2015, we are now able to offer the system to a growing number of centres in the UK and Europe. The Cellnovo system incorporates a miniaturised insulin pump with a discrete, tubeless, small and wearable device. It also allows patients to capture blood glucose readings, carbohydrate intake, bolus calculations, and activity levels. A first in insulin pump therapy, the system communicates data from the users pump, automatically to a secure online platform. This allows both patients and clinicians immediate access to real time diabetes management data and removes downloading requirements. For more information visit www.cellnovo.com

Diasend AB

Diasend simplifies life for people with diabetes and facilitates the work of their health care providers by optimizing diabetes data management. Thecompany’s comprehensive and market leading solution involves transmitting, storing and analyzing data from more than 130 different glucose meters,insulin pumps, CGM systems (continuous glucose monitoring) and leading activity trackers – allowing patients and caregivers to easily access the exactsame information. Diasend’s products and services, all FDA-approved and CE-marked, are currently used in 17 countries. Headquarters are located inGothenburg, Sweden – with subsidiaries in Chicago and London. For more information please visit Diasend

Roche Diabetes Care
Roche Diabetes Care is a global leader for innovative diabetes management solutions. For more than 40 years, the company has been dedicated to empower people with diabetes and healthcare professionals to optimally manage the condition. Today, the Accu-Chek portfolio encompasses smart solutions for bG monitoring, bolus advice and discreet remote control insulin pump technology with the Accu-Chek Combo and Accu-Chek Insight systems. Accu-Chek solutions contribute to optimal and personalised diabetes management, leading to improved outcomes and contributing to therapy success for people with diabetes.


Silver sponsors                              

Abbott Diabetes Care

 At Abbott, we’re committed to helping you live your best possible life through the power of health. For more than 125 years, we’ve brought new products and technologies to the world -- in nutrition, diagnostics, medical devices and branded generic pharmaceuticals -- that create more possibilities for more people at all stages of life. Today, 74,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.



With a shared vision of “creating a world without limits” for people with diabetes, Animas Corporation is a part of the Johnson & Johnson Diabetes Care Companies (JJDCC), a cross-company collaboration that reflects an ongoing commitment to better serve the diabetes community with integrated solutions that meet the needs of people with diabetes across the continuum of care. JJDCC includes LifeScan, Inc., a world leader in blood glucose monitoring; Calibra Medical, Inc. developer of a unique 3-day wearable insulin patch, and Animas Corporation, which provides a wide range of insulin delivery products for people living with diabetes, including the Animas ®  Vibe®  Insulin Pump and Continuous Glucose Monitoring (CGM) system, and the OneTouch®  Ping® Glucose Management System. Animas, from the Latin word meaning “true inner self or soul,” has been committed since 1996 to meeting individual patient needs through the development of life-performance technology and customer service 24 hours a day, 7 days a week, 365 days a year. To learn more about Animas, visit www.animascorp.co.uk.

Medtronic Ltd

Medtronic was founded in 1949.  Since then we have grown into a multinational company that uses technology to transform the way debilitating, chronic diseases are treated. Effective diabetes management and monitoring tools like the MinIMed® 640G with SmartGuard® and CareLink® Therapy Management Software can help people living with diabetes lead a full and active life.

To find out more about Medtronic’s diabetes products, services and support for healthcare professional, patients and carers please visit: www.medtronic-diabetes.co.uk . Medtronic UK offices are based in Watford, Herts


Dexcom Inc

Dexcom, Inc., headquartered in San Diego, CA, soon to be direct in the UK, is dedicated to helping people better manage their diabetes by providing exceptional continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. Our latest-generation CGM, the Dexcom G5® Mobile CGM System, is the first FDA-approved, fully mobile System for both adults and children 2 years and older. Patients can view not only their real-time glucose data via their hand held Receiver or compatible smartphone* but also share it with loved ones.  Our CGM features a 7-day-wear sensor as well as customizable alerts and a built-in low alarm to warn patients of the speed and direction of highs and lows. For more information, visit www.dexcom.com/en-GB

*To view a listing of compatible smartphones, visit www.Dexcom.com/compatibility

The sponsoring companies are not responsible for the content of this website.